圆锥角膜患者后房型有晶状体眼可植入胶原透镜的安全性与有效性:系统综述与荟萃分析
该系统综述与荟萃分析纳入16项观察性研究共397眼,评估后房型有晶状体眼可植入胶原透镜(ICL)在圆锥角膜患者中的安全性与有效性。术后裸眼远视力、显然验光柱镜、等效球镜和屈光性散光均显著改善,矫正远视力无统计学显著改善,未发生显著不良事件。作者结论认为ICL在圆锥角膜患者中安全有效,但受纳入研究观察性设计和随访时间有限的限制。
要点
- 纳入16项观察性研究共397眼,评估ICL在圆锥角膜患者中的安全性与有效性。
- 术后裸眼远视力、显然验光柱镜、等效球镜和屈光性散光均显著改善。
- 矫正远视力无统计学显著改善,未发生显著不良事件。
核心结论
- 作者结论认为,在圆锥角膜患者中使用ICL是安全有效的,可使多项视觉和屈光指标获得显著改善。
- 作者指出,其结果仍受纳入研究的观察性设计以及随访时间有限的限制。
研究设计与样本
- 系统综述与荟萃分析,遵循Cochrane协作网指南和系统综述与荟萃分析首选报告条目2020共识声明。
- 检索五个电子数据库和灰色文献,纳入评估圆锥角膜患者使用ICL的研究。
- 共纳入16项观察性研究,合计397眼。
- 采用随机效应荟萃分析计算标准化均数差(SMD)及其95%CI。
主要发现
- 术后矫正远视力无统计学显著改善(SMD:-0.97,95%CI:-1.99至0.05,P < .06)。
- 术后裸眼远视力显著改善(SMD:-5.41,95%CI:-0.704至-3.78,P < .05)。
- 术后显然验光柱镜显著改善(SMD:2.27,95%CI:1.83-2.70,P < .05)。
- 术后等效球镜显著改善(SMD:-4.66,95%CI:-5.63至3.68,P < .05)。
- 术后屈光性散光显著改善(SMD:2.22,95%CI:1.03-3.41,P < .05),未发生显著不良事件。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出,其结果受纳入研究的观察性设计限制。
- 作者指出,其结果受随访时间有限限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the safety and efficacy of phakic implantable collamer lenses (ICLs) in patients with keratoconus. DESIGN: Systematic review and meta-analysis. METHODS: We conducted a pre- and postintervention single-arm systematic review and meta-analysis in line with guidelines from the Cochrane Collaboration and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 Consensus Statement. We searched five electronic databases and the grey literature for any studies evaluating ICLs in the setting of keratoconus. Our primary outcomes were the corrected distance visual acuity, uncorrected distance visual acuity, and manifest cylinder astigmatism. Secondary outcomes included uncorrected near visual acuity, spherical equivalent, refractive astigmatism, higher-order aberrations, endothelial cell density, intraocular pressure, and incidence of adverse events. We summarized our analyses by calculating standardized mean differences (SMDs) with associated 95% confidence intervals (CIs) using random-effects meta-analysis. RESULTS: Sixteen observational studies, totaling 397 eyes, were eligible. Postoperatively, there was no statistically significant improvement in corrected distance visual acuity (SMD: -0.97, 95% CI: -1.99 to 0.05, P < .06); there was a statistically significant improvement in uncorrected distance visual acuity (SMD: -5.41, 95% CI: -0.704 to -3.78, P < .05), manifest cylinder (SMD: 2.27, 95% CI: 1.83-2.70, P < .05), spherical equivalent (SMD: -4.66, 95% CI: -5.63 to 3.68, P < .05), and refractive astigmatism (SMD: 2.22, 95% CI: 1.03-3.41, P < .05). No significant adverse events occurred. CONCLUSIONS: Use of ICLs in patients with keratoconus is safe and effective, resulting in significant improvements in a myriad of visual and refractive measures. Our results remain limited by the observational design of included studies as well as the limited follow-up duration.
引用
- Alkhabbaz AA, Karam MH, Pollmann AS, et al. Safety and Efficacy of Posterior Chamber Phakic Implantable Collamer Lenses in Patients with Keratoconus: A Systematic Review and Meta-Analysis. Am J Ophthalmol. 2024. PMID: 39613132. doi:10.1016/j.ajo.2024.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。